Biontech SENASDAQ:BNTX
- LAST PRICE100.6000
- TODAY'S CHANGE (%)1.8500 (1.8734%)
- Bid / Lots99.5000/ 2
- Ask / Lots101.0000/ 1
- Open / Previous Close99.5000 / 98.7500
- Day Range
- 52 Week Range
- Volume1,618,340
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BNTX |
|---|---|---|
| 09:32 ET | 22556 | 99.015 |
| 09:34 ET | 5465 | 98.62 |
| 09:36 ET | 6598 | 99.41 |
| 09:38 ET | 4988 | 99.3 |
| 09:39 ET | 3600 | 99.66 |
| 09:41 ET | 1700 | 99.735 |
| 09:43 ET | 11672 | 99.85 |
| 09:45 ET | 11802 | 100.06 |
| 09:48 ET | 21370 | 99.96 |
| 09:50 ET | 14472 | 100.105 |
| 09:52 ET | 1399 | 100.19 |
| 09:54 ET | 8690 | 100.8599 |
| 09:56 ET | 21186 | 101 |
| 09:57 ET | 11704 | 100.74 |
| 09:59 ET | 2481 | 100.74 |
| 10:01 ET | 900 | 100.84 |
| 10:03 ET | 12503 | 101 |
| 10:06 ET | 5589 | 100.67 |
| 10:08 ET | 9686 | 100.735 |
| 10:10 ET | 11768 | 101 |
| 10:12 ET | 3034 | 101 |
| 10:14 ET | 8720 | 101.43 |
| 10:15 ET | 13408 | 101.902 |
| 10:17 ET | 6124 | 102.24 |
| 10:19 ET | 11251 | 102.23 |
| 10:21 ET | 5686 | 102.7004 |
| 10:24 ET | 9737 | 102.67 |
| 10:26 ET | 14897 | 102.385 |
| 10:28 ET | 1999 | 102.16 |
| 10:30 ET | 3100 | 102.44 |
| 10:32 ET | 8647 | 102.725 |
| 10:33 ET | 11002 | 102.9 |
| 10:35 ET | 8024 | 102.97 |
| 10:37 ET | 15099 | 103.19 |
| 10:39 ET | 6310 | 103.46 |
| 10:42 ET | 5768 | 103.3395 |
| 10:44 ET | 8293 | 102.74 |
| 10:46 ET | 15561 | 102.6605 |
| 10:48 ET | 10805 | 102.715 |
| 10:50 ET | 3389 | 102.7125 |
| 10:51 ET | 2245 | 102.59 |
| 10:53 ET | 5472 | 102.74 |
| 10:55 ET | 3959 | 102.825 |
| 10:57 ET | 8419 | 101.76 |
| 11:00 ET | 8306 | 101.405 |
| 11:02 ET | 23107 | 101.365 |
| 11:04 ET | 2020 | 101.09 |
| 11:06 ET | 24273 | 100.19 |
| 11:08 ET | 5571 | 100.325 |
| 11:09 ET | 2300 | 100.7 |
| 11:11 ET | 8240 | 100.72 |
| 11:13 ET | 11583 | 100.6 |
| 11:15 ET | 16089 | 99.73 |
| 11:18 ET | 4000 | 99.73 |
| 11:20 ET | 5963 | 99.91 |
| 11:22 ET | 3153 | 99.79 |
| 11:24 ET | 4126 | 99.76 |
| 11:26 ET | 13720 | 99.98 |
| 11:27 ET | 4456 | 99.895 |
| 11:29 ET | 3566 | 99.655 |
| 11:31 ET | 16992 | 99.82 |
| 11:33 ET | 10720 | 99.7275 |
| 11:36 ET | 4996 | 99.98 |
| 11:38 ET | 4000 | 99.88 |
| 11:40 ET | 4246 | 99.96 |
| 11:42 ET | 5249 | 99.84 |
| 11:44 ET | 6372 | 99.65 |
| 11:45 ET | 4217 | 99.76 |
| 11:47 ET | 15895 | 99.9 |
| 11:49 ET | 813 | 99.9507 |
| 11:51 ET | 1800 | 99.79 |
| 11:54 ET | 547 | 99.84 |
| 11:56 ET | 3269 | 99.685 |
| 11:58 ET | 3908 | 99.75 |
| 12:00 ET | 1621 | 99.735 |
| 12:02 ET | 1200 | 99.85 |
| 12:03 ET | 2300 | 99.99 |
| 12:05 ET | 3373 | 100.18 |
| 12:07 ET | 5973 | 100.5 |
| 12:09 ET | 1200 | 100.295 |
| 12:12 ET | 4320 | 100.05 |
| 12:14 ET | 650 | 100.16 |
| 12:16 ET | 400 | 100.345 |
| 12:18 ET | 3785 | 100.59 |
| 12:20 ET | 1000 | 100.715 |
| 12:21 ET | 2300 | 100.745 |
| 12:23 ET | 3374 | 100.64 |
| 12:25 ET | 1812 | 100.41 |
| 12:27 ET | 11228 | 100.53 |
| 12:30 ET | 4057 | 100.47 |
| 12:32 ET | 9618 | 100.32 |
| 12:34 ET | 3020 | 100.11 |
| 12:36 ET | 1278 | 100.21 |
| 12:38 ET | 1300 | 100.255 |
| 12:39 ET | 1870 | 100.29 |
| 12:41 ET | 2957 | 100.18 |
| 12:43 ET | 3240 | 100.09 |
| 12:45 ET | 1900 | 100.235 |
| 12:48 ET | 2400 | 100.24 |
| 12:50 ET | 4530 | 99.72 |
| 12:52 ET | 1100 | 99.96 |
| 12:54 ET | 4055 | 100.01 |
| 12:56 ET | 1827 | 99.69 |
| 12:57 ET | 900 | 99.69 |
| 12:59 ET | 2044 | 99.6085 |
| 01:01 ET | 1400 | 99.81 |
| 01:03 ET | 1900 | 99.89 |
| 01:06 ET | 9606 | 99.96 |
| 01:08 ET | 700 | 99.98 |
| 01:10 ET | 1356 | 100 |
| 01:12 ET | 10428 | 100.27 |
| 01:14 ET | 7888 | 100.41 |
| 01:15 ET | 3644 | 100.515 |
| 01:17 ET | 2169 | 100.47 |
| 01:19 ET | 2060 | 100.47 |
| 01:21 ET | 2458 | 100.41 |
| 01:24 ET | 2200 | 100.51 |
| 01:26 ET | 1600 | 100.58 |
| 01:28 ET | 1500 | 100.83 |
| 01:30 ET | 1862 | 100.9 |
| 01:32 ET | 3896 | 100.765 |
| 01:33 ET | 729 | 100.72 |
| 01:35 ET | 2900 | 100.78 |
| 01:37 ET | 800 | 100.79 |
| 01:39 ET | 3500 | 100.62 |
| 01:42 ET | 1305 | 100.715 |
| 01:44 ET | 800 | 100.76 |
| 01:46 ET | 5300 | 100.34 |
| 01:48 ET | 100 | 100.35 |
| 01:50 ET | 1100 | 100.33 |
| 01:51 ET | 5045 | 100.56 |
| 01:53 ET | 5351 | 100.24 |
| 01:55 ET | 701 | 100.26 |
| 01:57 ET | 6343 | 100.42 |
| 02:00 ET | 2217 | 100.19 |
| 02:02 ET | 1300 | 100.201 |
| 02:04 ET | 400 | 100.31 |
| 02:06 ET | 800 | 100.31 |
| 02:08 ET | 3100 | 100.28 |
| 02:09 ET | 3475 | 100.36 |
| 02:11 ET | 2238 | 100.37 |
| 02:13 ET | 2703 | 100.375 |
| 02:15 ET | 200 | 100.43 |
| 02:18 ET | 400 | 100.43 |
| 02:20 ET | 1000 | 100.385 |
| 02:22 ET | 2667 | 100.55 |
| 02:24 ET | 5900 | 100.475 |
| 02:26 ET | 800 | 100.445 |
| 02:27 ET | 1000 | 100.55 |
| 02:29 ET | 2500 | 100.455 |
| 02:31 ET | 1692 | 100.485 |
| 02:33 ET | 1100 | 100.495 |
| 02:36 ET | 2340 | 100.435 |
| 02:38 ET | 1000 | 100.5 |
| 02:40 ET | 570 | 100.4895 |
| 02:42 ET | 3500 | 100.465 |
| 02:44 ET | 4600 | 100.4399 |
| 02:45 ET | 100 | 100.44 |
| 02:49 ET | 5900 | 100.18 |
| 02:51 ET | 1550 | 100.14 |
| 02:54 ET | 1864 | 100.32 |
| 02:56 ET | 300 | 100.33 |
| 02:58 ET | 600 | 100.33 |
| 03:00 ET | 1977 | 100.25 |
| 03:02 ET | 3143 | 100.35 |
| 03:03 ET | 6356 | 100.305 |
| 03:05 ET | 100 | 100.29 |
| 03:07 ET | 5739 | 100.52 |
| 03:09 ET | 2838 | 100.56 |
| 03:12 ET | 3136 | 100.59 |
| 03:14 ET | 1708 | 100.57 |
| 03:16 ET | 2344 | 100.51 |
| 03:18 ET | 3700 | 100.42 |
| 03:20 ET | 1500 | 100.45 |
| 03:21 ET | 2000 | 100.39 |
| 03:23 ET | 200 | 100.4 |
| 03:25 ET | 400 | 100.4 |
| 03:27 ET | 1326 | 100.405 |
| 03:30 ET | 4722 | 100.26 |
| 03:32 ET | 13731 | 100.145 |
| 03:34 ET | 4404 | 100.33 |
| 03:36 ET | 4924 | 100.3 |
| 03:38 ET | 2766 | 100.155 |
| 03:39 ET | 3221 | 100.19 |
| 03:41 ET | 9136 | 100.035 |
| 03:43 ET | 3400 | 100 |
| 03:45 ET | 11920 | 100.105 |
| 03:48 ET | 8060 | 100.515 |
| 03:50 ET | 5810 | 100.85 |
| 03:52 ET | 21666 | 100.66 |
| 03:54 ET | 10865 | 100.76 |
| 03:56 ET | 31703 | 100.7 |
| 03:57 ET | 33551 | 100.455 |
| 03:59 ET | 22713 | 100.6 |
Today
Investigational Acasunlimab (DuoBody(R) -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC), from 3 hours ago by Dow Jones
3 hours ago by Dow JonesInvestigational Acasunlimab (DuoBody(R) -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC), from 3 hours ago by Dow Jones
3 hours ago by Dow Jones
May 30, 2024
DJ BioNTech Price Target Maintained With a $113.00/Share by HC Wainwright & Co., from 7:13AM ET on Thursday May 30, 2024 by Dow Jones
7:13AM ET on Thursday May 30, 2024 by Dow Jones
May 29, 2024
BioNTech and CEPI Expand Partnership to Strengthen Africa's mRNA Vaccine Ecosystem, from 8:00AM ET on Wednesday May 29, 2024 by Dow Jones
8:00AM ET on Wednesday May 29, 2024 by Dow Jones
May 28, 2024
DJ BioNTech Price Target Maintained With a $113.00/Share by HC Wainwright & Co., from 6:47AM ET on Tuesday May 28, 2024 by Dow Jones
6:47AM ET on Tuesday May 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biontech SE | 23.9B | 195.1x | --- |
Charles River Laboratories International Inc | 10.7B | 24.5x | +15.57% |
Incyte Corp | 13.0B | 17.5x | +39.11% |
Beigene Ltd | 16.0B | -19.7x | --- |
ICON PLC | 26.9B | 39.4x | +4.68% |
Alnylam Pharmaceuticals Inc | 18.8B | -54.8x | --- |
Company Information
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Contact Information
- Headquarters
- An der Goldgrube 12MAINZ, Germany 55131
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Supervisory Board
- Helmut Jeggle
- Chief Executive Officer, Member of the Management Board
- Ugur Sahin
- Independent Deputy Chairman of the Supervisory Board
- Ulrich Wandschneider
- Chief Financial Officer
- Jens Holstein
- Chief Operating Officer, Member of the Management Board
- Sierk Poetting
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $23.9B |
|---|---|
Revenue (TTM) | $3.0B |
Shares Outstanding | 237.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.26 |
EPS | $0.52 |
Book Value | $92.33 |
P/E Ratio | 195.1x |
Price/Sales (TTM) | 8.1 |
Price/Cash Flow (TTM) | 72.7x |
Operating Margin | -17.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
